SBRA — Stock Film
STOCK FILMSCENE 1/11SBRA · $20.39
Stock Expert AI presents
SBRA
Sabra Health Care REIT, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Sabra Health Care REIT, Inc. A quick introduction.

On the stock market since 2002, it operates in the world of real estate. It has 58 employees. Now — the numbers.

on the stock market since 2002
58 employees
$5.1B market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $20 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 20%

This is an established company with proven profits.

THE SALES TREND
Sales are growing — but slowly for a company this size.

Average growth of 8% a year over the last 4 years. Red columns mark years that ended in a loss.

$569.5M
2021
$624.8M
2022
$647.5M
2023
$703.2M
2024
$774.6M
2025
Cash on hand:
$0
Total debt:
$0
The debt outweighs the cash.

The gap is $2.5B. In times of high interest rates, a gap like that can squeeze a company.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
76
strong

Clearly above the class average — a step short of the very top.

FINANCIAL STRENGTH
89
very strong

A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.

VALUATION
53
average

The price isn’t cheap next to earnings — that’s why this grade sits in the middle.

GROWTH
45
weak

Clearly below the class average.

PRICE MOMENTUM
50
average

The price is looking for direction — no strong breakout, no collapse.

WORTH WATCHING

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking10/10
Few are betting against it10/10
WEAK SPOTS
Executives aren’t buying3/10
WORTH WATCHING

Executive Buying: The trades send no strong signal of confidence.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 9% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
A fat but narrowing margin

The net profit margin is 20% — still a thick cushion, though costs have been eating into it lately.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $1.20 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
A rich price tag

The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 45/100.

3
THE RISKS · 3/3
Executives aren’t buying

No clear buy-side message is coming from the executive floor. Council score: 3/10.

FINALE · THE GRADE
B
0 / 100 · MoonshotScore

On our five-subject report card, SBRA sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: SBRA is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Aug 21, 2026 · stockexpertai.com · Stock Film